Trump Hails Record Drop in US Prescription Drug Prices
Trump celebrates federal data showing prescription drug prices fell 0.8% in July and 3.1% over the year, crediting his most-favored-nation deals and the TrumpRx website.
WASHINGTON D.C. — Donald Trump touted a record decline in US prescription drug prices, crediting his administration’s pricing deals with pharmaceutical companies.
Here is the full post on truthsocial: “Trump Effect: Prescription Drug Prices Fall At Record-Breaking Pace: https://www.breitbart.com/politics/2026/08/12/trump-effect-prescription-drug-prices-fall-for-fifth-month-this-year/” on August 28, 2026 at 11:21 AM ET.
This is Trump’s 5th message released today, and the last post was two hours ago, and it is not part of a thread. On average, Trump produces 18 posts per day since his inauguration on January 20, 2025. The move fits a broader pattern in Trump’s recent messaging, with 52 of his 604 posts over the last 30 days classified as Domestic Policy posts.
Prescription drug prices fell 0.8 percent in July, a steep monthly decline shown in the government’s consumer price index, according to breitbart. Prices have fallen in five of the last seven months and have not increased at all this year, and they are down 3.1 percent from a year ago, according to breitbart. Over the last six months, prescription drug prices have fallen at an annualized rate of 6.6 percent, the sharpest drop on record, according to breitbart.
The 3.1 percent year-over-year drop marked the steepest such decline since 1963, according to pbs. The White House said the plunge resulted from the Republican president’s most-favored-nation drug deals with pharmaceutical firms and the TrumpRx website, which it said are delivering real relief to American families, according to pbs.
President Donald J. Trump hails a record decline in U.S.
Joyce N. Boghosian / The White House
© copyright Flickr with permission
Drug pricing experts said the picture is more complicated than a single cause. Other factors, including a law from Democratic President Joe Biden’s time in office that allowed Medicare to negotiate with pharmaceutical companies, are potentially more significant contributors to the latest figures, according to pbs. Generic and biosimilar products entering the market have also driven down the price of expensive brand-name and biologic drugs, according to pbs. “I don’t think we can attribute this price reduction to any one specific policy change or initiative,” said Juliette Cubanski, a vice president and director of the Program on Medicare Policy at the healthcare research nonprofit KFF, according to pbs.
Trump signed an executive order on May 12, 2025, titled “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients,” according to whitehouse.gov. The order directed the administration to bring American drug prices in line with those paid by similar nations, according to whitehouse.gov. He launched TrumpRx.gov on February 5, 2026, featuring drugs from the first five manufacturers to reach pricing deals, AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk and Pfizer, according to whitehouse.gov. Patients purchasing through the site can see reductions on 40 of the most popular and expensive branded medicines, with the monthly price of Ozempic falling from $1,028 to an average of $350, according to whitehouse.gov.
Trump promised in December that American drug prices would come down fast and soon be among the lowest in the developed world, according to breitbart. He touted the earlier order as one of the most consequential in US history, claiming prices would fall almost immediately by 30 percent to 80 percent, according to bbc. Experts remained skeptical of those claims at the time, and stock market moves indicated investors expected little immediate effect, according to bbc.
Efforts to lower US drug costs predate the current push. Trump signed four executive orders on July 24, 2020, aimed at reducing prescription drug costs, according to hematology. The measures included steps to increase drug importation and a favored-nations plan linking payments for certain Medicare Part B drugs to prices abroad, according to hematology. None of those orders took effect immediately, as each required a rulemaking process, according to hematology.
NewsFindr Chart Maker
Photo by Zenger real-time database of all Truth Social posts.
Zenger analysis
Photo by Zenger analysis